期刊文献+

胰岛素对雷公藤多甙联合烟酰胺方案干预LADA疗效的影响(英文)

Effects of insulin on intervention therapy of Tripterygium Polyglycoside combine with Nicotinamide in LADA patients
下载PDF
导出
摘要 目的对比研究胰岛素(强化治疗)与口服降糖药二甲双胍对雷公藤多甙联合烟酰胺方案干预LA-DA早期患者疗效的影响。方法病程在1年内LADA患者62例,随机分为胰岛素强化治疗组(A组)与二甲双胍组(B组),两组均使用相同的雷公藤多甙联合烟酰胺干预方案。随访时间24月,A、B两组实际完成随访观察各30例。结果两组C肽水平均较治疗前显著升高(P<0.05),但A组C肽水平高于B组(P<0.05);A组与B组分别有10例与7例ICA阳性病例转阴;两组患者的血清sIL-2R与LPO水平均较治疗前明显下降(P<0.01 ̄0.05)。结论雷公藤多甙联合烟酰胺方案对LADA早期患者具有调节免疫,保护残存胰岛β细胞功能的作用。胰岛素强化治疗可提高该方案的干预效果。 [Objective] To compare the clinical efficacy between insulin intensive therapy and oral hypoglycemic agent metformin with the intervention therapy of Tripterygium polyglycoside combined with Nnicotinamide on Latent onset autoimmune diabetes mellitus (LADA) patients. [Method] 62 cases of newly diagnosed LADA patients were randomly divided into insulin group (Group A) and metformin group(Group B), and the same intervention therapy was used in both of the two groups. During 24 months of follow-up intervention, 30 patients finished this clinical study in each group. [Results] Values of C-peptide in group A were significantly higher than that in group B (P 〈0.05), and the values of C-peptide were increased in the both of the groups compared with the basic value before intervention (P 〈0.05). ICA(+) of 10 cases in group A and 7 cases in group B became negative respectively. The level of sIL-2R and LPO was significantly decreased in both of the groups after intervention (P 〈0.01-0.05). [Conclusion] Results suggested that the intervention therapy of Tripterygium polyglycoside combined with nicotinamide may play a role in the immunity regulation, decreasing the titer of islet cell antibodies and sIL-2R, protecting the islet function in the early LADA patients, which could be improved by the insulin intensive therapy.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第15期2241-2244,共4页 China Journal of Modern Medicine
关键词 成人迟发性自身免疫性糖尿病 雷公藤多甙 烟酰胺 胰岛素 LADA Tripterygium polyglycoside Nicotinamide Insulin
  • 相关文献

参考文献6

  • 1LOHMANN T, ROTGER J, SEISSLER J, et al. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40[J]. Diabetes Care, 1997, 20: 524-529.
  • 2TORN C, LANDIN-OLSSON M, LERNMARK A, et al. Combination of beta-cell-specific autoantibodies at diagnosis of diabetes in young adults reflects different course of beta-cell damage[J]. Autoimm-unity, 2001, 33:115-120.
  • 3CARLA J, LEONARD C. Guidelines for intervention trails in subiects with newly diagnosed type-ldiabetes[J]. Diabetes, 2003,52: 1059-1062.
  • 4LIU JIANG-HUA, DUAN SHI-FANG, LIU ZI-WEN, et al. Clinical study of Tripterygrium associated with Nicotinamide in the treatment of LADA[J]. Am J Chin Med, 2001, 3: 9-11.
  • 5DIABETES control and complication trail research group:The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-depend diabetes mellitus[J]. N Engl J Med, 1993, 329: 977-986.
  • 6KOBAYASH T, WAKANISHI K, MURASE T, et al. Small dose of subcutaneously insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with Clinical features of NIDDM[J]. Diabetes, 1996, 45: 622-626.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部